Regulon

Regulon: R-1082

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
16-0.40440510Pr-60Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5725 ENSG00000011304 PTBP1 A6NLN1
63897 ENSG00000068097 HEATR6 Q6AI08
55205 ENSG00000074657 ZNF532 Q9HCE3
51729 ENSG00000084463 WBP11 Q9Y2W2
9777 ENSG00000101337 TM9SF4 Q92544
10664 ENSG00000102974 CTCF P49711
9110 ENSG00000108389 MTMR4 Q9NYA4
55188 ENSG00000111785 RIC8B A0A024RBG9
10274 ENSG00000118007 STAG1 Q8WVM7
10250 ENSG00000133226 SRRM1 Q8IYB3
10262 ENSG00000143368 SF3B4 Q15427
142 ENSG00000143799 PARP1 P09874
51631 ENSG00000146963 LUC7L2 Q9Y383
5747 ENSG00000169398 PTK2 E5RH01
55802 ENSG00000272886 DCP1A Q9NPI6
10236 ENSG00000282958 HNRNPR O43390

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUCAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
PAMIPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor31
GSK-2256098PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
BI-853520PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
OLAPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor42
TALAZOPARIBPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
VS-4718PTK2Small moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
DEFACTINIBPTK2BSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor20
RUCAPARIB CAMSYLATEPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor40
VELIPARIBPARP1Small moleculeINHIBITORPARP 1, 2 and 3 inhibitor32
2X-121TNKS2Small moleculeINHIBITORPoly [ADP-ribose] polymerase-1 inhibitor20
NIRAPARIBPARP2Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor42
NIRAPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
CEP-37440ALKSmall moleculeINHIBITORFocal adhesion kinase 1 inhibitor10
TALAZOPARIB TOSYLATEPARP1Small moleculeINHIBITORPoly [ADP-ribose] polymerase 2 inhibitor40
CONTELTINIBPTK2Small moleculeINHIBITORProtein tyrosine kinase 2 beta inhibitor10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1082

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs